Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

View source ↗

Summary

A pregnancy registry is being established to collect pregnancy, neonatal, and infant outcomes in pregnant women exposed to QUVIVIQ (lemborexant). The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUVIVIQ (daridorexant)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia | Status: RECRUITING